CURRICULUM VITAE

PERSONAL DETAIL

DR. ELSA HANIFFAH MEJIA MOHAMED

Department of Pharmacology
Faculty of Medicine
 
  79676634
  elsa@um.edu.my
 Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, W.Persekutuan Kuala Lumpur, Malaysia
 
ResearcherID Link
   http://www.researcherid.com/rid/B-8451-2010

ACADEMIC QUALIFICATION
(Qualification), (Institution).


PROFESSIONAL
(Organisation), (Role), (Year), (Level).

  • Malaysian Society of Pharmacology and Physiology, Ordinary Member, 2018 to 2019, (National)
  • Islamic Medical Association of Malaysia, Exco Member, 2018 to 2020, (National)

ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).

  • Acting College Master, Ibnu Sina Residential College, Deputy Vice Chancellor(Student Affairs), 01/01/2008 to 31/01/2008
  • Academic advisor, Faculty, 01/09/2016 to 31/08/2017 (Stage 1 Group 7 academic advisor)
  • Auditor, University Malaya, 09/05/2016 to 23/05/2016 (Auditor for UM Internal Audit 2016)
  • AJK Penilaian Sebutharga, Faculty, 08/04/2016 to 08/04/2016 (Perkhidmatan Whole Exome Sequencing untuk Projek Pre-Term Birth, Jabatan Farmakologi, Fakulti Perubatan, Universiti Malaya)
  • Ahli Jawatankuasa Ijazah Tinggi Jabatan (JKITJ), Faculty, 11/03/2016 (Proposal evaluator)
  • Coordinator, Faculty, 11/03/2016 (UMMP Stage 1)
  • Academic advisor, Faculty, 01/02/2016 to 31/08/2016 (UMMP St2 Gp 13)
  • PPP Grant Evaluator, Faculty, 01/10/2015 to 30/09/2018 (Jawatankuasa Penilai PPP)
  • Academic Advisor, Faculty, 01/09/2015 to 01/08/2016 (Stage 1 Group 13 UMMP Programme)
  • Academic Advisor, Faculty, 01/09/2015 to 31/08/2016 (Group 13 Stage 2 UMMP Programme)
  • Lead Auditor, University Malaya, 28/06/2010 to 16/07/2010 (Lead Auditor)
  • College Secretary, University Malaya, 01/06/2010 to 30/11/2010 (Kolej Kediaman Ketiga)
  • College Secretary, University Malaya, 05/08/2008 to 31/05/2010 (Kolej Kediaman Kesepuluh)
  • Chief Auditor, University Malaya, 09/06/2008 to 16/06/2008
  • College Secretary, University Malaya, 03/09/2007 to 31/07/2008 (Kolaj Kediaman Keenam)
  • Document Controller, University Malaya, 01/09/2007 to 30/11/2010 (Kolej Kediaman Keenam, Kolej Kediaman Kesepuluh, Kolej Kediaman Ketiga )
  • College Treasurer, University Malaya, 01/08/2004 to 31/08/2007 (Kolej Kediaman Keenam)

AREAS OF EXPERTISE
(Area).

  • Molecular Pharmacology (Pharmacogenomics, Next generation sequencing, exome sequencing, bioinformatics)


RECENT SELECTED PUBLICATIONS
(Publication).

Chapter in Book

2018
  • Tan-Koi W.C., Limenta M, Mejia Mohamed, E. H., Deoon Lee, E. J. (2018). Chapter 11 - The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging and Pharmacovigilance. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation (Lam, Y.W. F. & Stuart A Scott., eds.), pp. 289-318. Academic Press, San Diego 

2013
  • Mejia Mohamed, E. H., Huei-xin, L., Poh, J., Toh, D. & Deoon Lee, E. J. (2013). Chapter 10 - The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation (Lam, Y.- W. F. & Cavallari, L. H., eds.), pp. 367-404. Academic Press, San Diego 
Article in Academic Journals

2018
  • Koo, S. H., Deng, J., Ang, D. S. W., Hsiang, J. C., Lee, L. S., Aazmi, S., . . . Ang, T. L. (2018). Effects of proton pump inhibitor on the human gut microbiome profile in multi-ethnic groups in Singapore. Singapore Medical Journal. doi:10.11622/smedj.2018152 (ISI-Indexed)
  • Islam, M., Mohamed, E. H., Esa, E., Kamaluddin, N. R., Zain, S. M., Yusoff, Y., . . . Zakaria, Z. (2018). Abstract B86: Circulating cytokines, chemokines, and small molecules follow distinct expression patterns in acute myeloid leukemia. Cancer Immunology Research, 6(9 Supplement), B86-B86. doi:10.1158/2326-6074.tumimm17-b86 (ISI-Indexed)

2017
  • Islam M, Mohamed EH, Esa E, Kamaluddin NR, Zain SM, Mat Yusoff Y, Assenov Y, Mohamed Z, Zakaria Z. Circulating cytokines and small molecules follow distinct expression patterns in acute myeloid leukaemia. British Journal of Cancer. 2017; 117(10):1551-1556. (ISI-Indexed)

2015
  • Whole Exome Sequencing Approach to Identify Genetic Variants Causing Sudden Unexplained Death Syndrome within a Normal Population. 2015 Golden Helix Symposium - Next Generation Pharmacogenomics. March 11-13, 2015, Kuala Lumpur, Malaysia: Abstracts. Public Health Genomics 2015;18(suppl 1):1-51 (ISI-Indexed)

2014
  • 15Roffeei, S.N. , Mohamed, Z., Reynolds, G.P., Said, M.A., Hatim, A., Mohamed, E.H.M. Aida, S.A., Zainal, N.Z.2014. Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics. Pharmacogenomics 15 (4), 477-485. (ISI-Indexed)

2011
  • Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy. B.S. Haerian, K.S. Lim, E.H.M. Mohamed, H.J. Tan, C.T. Tan, A.A. Raymond, C.P. Wong, S.W. Wong, Z. Mohamed. Seizure: European Journal of Epilepsy - September 2011 (Vol. 20, Issue 7, Pages 546-553, DOI: 10.1016/j.seizure.2011.04.003) (ISI cited) (ISI-Indexed)
  • Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy. B.S. Haerian, K.S. Lim, E.H.M. Mohamed, H.J. Tan, C.T. Tan, A.A. Raymond, C.P. Wong, S.W. Wong, Z. Mohamed. Seizure: European Journal of Epilepsy - June 2011 (Vol. 20, Issue 5, Pages 387-394, DOI: 10.1016/j.seizure.2011.01.008) (ISI cited) (ISI-Indexed)
  • Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients. BS Haerian, KS Lim, HJ Tan, EHM Mohamed, CT Tan, AA Raymond, CP Wong, SW Wong, H Omar, H Roslan, Z Mohamed. Epileptic disord. 2011 Mar;13(1):65-75. (ISI cited) (ISI-Indexed)
  • Mohamed EHM, Tan KS,Mohd Ali J, Mohamed Z.TT genotype of the methylenetetrahydrofolate reductase C677T polymorphism is an important determinant for homocysteine levels in multi-ethnic Malaysian ischaemic stroke patients.ANNALS OF THE ACADEMY OF MEDICINE, SINGAPORE 40(4):186-91 APRIL 2011 Department of Pharmacology, University of Malaya, Kuala Lumpur, Malaysia. Impact Factor: 1.22 (ISI-Indexed)

2010
  • ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis. BS Haerian, H Roslan, AA Raymond, CT Tan, SZ Zulkifli, KS Lim, EHM Mohamed, HJ Tan, Z Mohamed. Seizur: Eur J Epilepsy (2010) 19(6):339-346 (ISI cited) (ISI-Indexed)

2009
  • Role of ABCB1 C3435T Variant in Response to Antiepileptic Drugs in Epilepsy: A Review Haerian BS, Mohamed Z, Mohamed EHM, Lim KS, Tan HJ, Tan CT, Raymond AA Med & Health 2009; 4(2): 64-75 (Non-ISI/Non-SCOPUS)

AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Level), (Source).

  • MICRORNA-MRNA REGULATORY RELATIONSHIP IN NORMAL KARYOTYPE ACUTE MYELOID LEUKAEMIA ASSESSED BY CLINICAL AND COMPUTATIONAL DATA, Consultant, 2019 - 2020, Fundamental Research Grant Scheme (FRGS), (National)
  • The Relationship between ER Stress Response and Inflammasome Activation in IL-1 -Induced Colorectal Cancer Metastasis, Consultant, 2019 - 2021, RU Geran - Fakulti Program, (National)
  • Optimising The Use Of Virtual Learning Space To Improve Student Engagement And Learning Outcome In Team-based Learning (tbl) Module, Consultant, 2018 - 2019, RU Geran, (National)
  • MICRORNA-MRNA REGULATORY RELATIONSHIP IN NORMAL KARYOTYPE ACUTE MYELOID LEUKAEMIA ASSESSED BY CLINICAL AND COMPUTATIONAL DATA, Co-Investigator, 2018 - 2021, Fundamental Research Grant Scheme (FRGS), (National)
  • Association of High Mobility Group Box-1 (HMGB1) and Soluble Receptor for Advanced Glycation End Products (SRAGE) Plasma Levels in Acute Myeloid Leukemia (AML) Patients, Principal Investigator(PI), 2018 - 2019, UMSC CA.R.E, (National)
  • Association of High Mobility Group Box-1 (HMGB1) and Soluble Receptor for Advanced Glycation End Products (sRAGE) Plasma Levels in Acute Myeloid Leukemia (AML) Patients, Principal Investigator(PI), 2018 - 2019, Private Funding, (National)
  • Transcriptome Analyses of cytogenetically normal adult acute myeloid leukaemia, Co-Investigator, 2018 - 2020, Private Funding, (National)
  • EVALUATING THE PRESCRIBING READINESS OF MEDICAL STUDENTS IN MALAYSIA USING THE PRESCRIBING INITIATIVES FOR LIFELONG LEARNING (PILL), Co-Investigator, 2017 - 2018, NONE, (National)
  • Enhancing Students' Engagement During In-class Learning Through Implementation Of Team-based Learning (tbl), Principal Investigator(PI), 2017 - 2018, RU Geran, (National)
  • ENHANCING STUDENTS' ENGAGEMENT DURING IN-CLASS LEARNING THROUGH IMPLEMENTATION OF TEAM-BASED LEARNING (TBL), Principal Investigator(PI), 2017 - 2018, UM-LiTeR 2017, (National)
  • Cytokines and Chemokines Profiling in Adult Malaysian Acute Myeloid Leukemia (AML) patients, Co-Investigator, 2016 - 2017, MOH-NIH, (National)
  • Harnessing whole exome sequencing platform for mutation profiling of cytogenetically normal acute myeloid leukaemia in Malaysian population, Co-Investigator, 2016 - 2017, MOH-NIH, (National)
  • Pharmacogenomics of Metabolic SYndrome in Schizophrenia, Principal Investigator(PI), 2010 - 2011, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Tajuk Projek/ Project title: Original Title: Population pharmacokinetics and pharmacogenomics of phenytoin in the Malaysian Population Revised title: Association of ABCB1 (MDR1) and SCN1A polymorphism and carbamazepine in epileptic patients in University Malaya Medical Center (UMMC), Principal Investigator(PI), 2008 - 2009, Short Term Research Fund (Vote F)(PJP), (National)
  • Insertion/deletion polymorphism of angiotensin 1 converting enzyme in Malaysian multi-ethnic stroke population, Principal Investigator(PI), 2004 - 2005, Short Term Research Fund (Vote F)(PJP), (National)

CONSULTATION PROJECT/CONSULTANCY
(Project title), (Role), (From)-(Until), (Organisation).

  • Steering Committee of the Asia Pacific Federation of Pharmacology Scientific Meeting 2028, 2018-2018, APFP
  • INTERPROFESSIONAL PRESCRIBING SKILLS (PILL-1) TRAINING WORKSHOP FOR MBBS (UMMP) STAGE 3.2 & YEAR 4 BPHARM 2017/2019, 2018-2018, FACULTY OF MEDICINE
  • Training of Trainers for Prescribing Skills Workshop, UiTM, 2018-2018, UiTM
  • Audit Kualiti Dalaman Universiti Malaya Bil 19/2018, 2018-2018, Universiti Malaya
  • Interprofessional Prescribing Skills (PILL-1) Training Workshop for MBBS (UMMP) Stage 3.2 & Year 4 BPharm, 2017/2018, 2017-2017, UM
  • Interprofessional Prescribing Skills (PILL-1) Training Workshop for MBBS (UMMP) Stage 3.2 & Year 4 BPharm, 2017/2018, 2017-2017, UM
  • Prescribing Skills Training Workshop, February 2016, 2016-2016, Faculty of Medicine, University Malaya
  • Prescribing Skills Training Workshop, March 2016, 2016-2016, Faculty of Medicine, University Malaya
  • Prescribing Skills Training Workshop, April 2016, 2016-2016, Faculty of Medicine, University Malaya
  • Prescribing Skills Training Workshop, MBBS Phase IIIB, Session 2015/2016, 2015-2015, Faculty of Medicine, University Malaya

AWARDS AND RECOGNITIONS
(Name of Award), (Awarding Institution), (Year Awarded), (Level).

  • Bronze Award in 'Learning Improvement and Teaching Enhancement Research Conference 2018' , Universiti Malaya, 2018, (University)

PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).

PRESENTER
  • Prevalence of genetic polymorphisms for 5,10-methylenetetrahydrofolate reductase (MTHFR) and Insertion Deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene in University Malaya Medical Centre (UMMC) ischaemic stroke population, International Conference on Health Sciences, 2005-05-06 to 2005-05-08, University Malaya Medical Centre, (National)
  • C677T polymorphism of methylenetetrahydrofolate reductase gene and increased plasma concentration in ischaemic stroke multi ethnic Malaysian population, The First North-South Workshops on Pharmacogenomics, 2005-12-12 to 2005-12-13, (National)
  • Angiotensin-converting enzyme deletion (ACE D) polymorphism and ischaemic stroke in multi-ethnic Malaysian population, The 15th World Congress of Pharmacology (IUPHAR) , 2006-07-02 to 2006-07-07, IUPHAR, (International)
POSTER
  • Angiotensin-converting enzyme deletion (ACE D) polymorphism and ischaemic stroke in multi ethnic Malaysian population, Seminar Hasil Penyelidikan Universiti Malaya 2006, 2006-09-06 to 2006-09-07, University Malaya, (University)
  • Polymorphism of the Dopamine D3 Receptor Gene in Multi-Ethnic Patients with Schizophrenia. Zahurin Bt Mohamed, Siti Zaleha Suki, Elsa Haniffah Mejia Mohamed, Vijaya L Raj and Nor Zuraida Zainal, International Conference on Pharmacogenomics, 2008-04-10 to 2008-04-13, (International)
  • Association of ABCB1 (MDR1) and SCN1A polymorphism with resistance to carbamazepine in Malaysian epileptic patients. Batoul Sadat Haerian, EHM Mohamed, Z.Mohamed, VL Raj, KS Lim and CT Tan, Fifth Epilepsy Congress, Tehran , 2008-11-04 to 2008-11-06, (International)
  • Association of genetic polymorphism in the human pregnane X receptor/NR1I2 with response to carbamazepine in epilepsy. , International Conference on Personalized Medicine 2009. , 19-20th September 2009. (International) (Poster), 2009-09-19 to 2011-01-20
  • Homocysteine, Vitamin B12 and Folate in Post Ischaemic Stroke Patients from University Malaya Medical Centre, Kuala Lumpur. EHM Mohamed, Tan KS, Z Mohamed, Ali JM, Annual Scientific Meeting of the Malaysian Society of Neuroscience, 2010-05-21 to 2010-05-24, (National)
  • Association of FABP2 A54T Polymorphism with Sodium Valproate Responsiveness in Malaysian Epilepsy Patients. EHM Mohamed, Haerian BS, Mohammad Noor N, Lim KS, Tan HJ, Tan CT, Raymond AA, Wong CP, Mohamed Z, 24th Malaysian Society of Pharmacology & Physiology Scientific Meeting 2010, 2010-06-02 to 2010-06-03, (National)
  • Whole Exome Sequencing Approach to identify of Genetic Variants Causing Sudden Unexplained Death Syndrome , Molecular Med TriCon, 2014 , 2014-02-10 to 2014-02-12, Cambridge Health Institute, (International)
ORAL
  • Prevalence of the Genetic Polymorphism for 5,10-Methylenetetrahydrofolate reductase (MTHFR) in Multi Ethnic Malaysian Ischaemic Stroke Population- Awarded Best Scientific Award, Annual Scientific Meeting of the Malaysian Society of Neurosciences , 2004-06-18 to 2004-06-18, (National)
  • Enhancing students' engagement during in-class learning through implementation of team-based learning (TBL), LEARNING IMPROVEMENT AND TEACHING ENHANCEMENT RESEARCH (LiTeR) Conference 2018, 2018-04-04 to 2018-04-05, Academic Enhancement and Leadership Development Centre (ADeC), (National)
OTHERS
  • ABCB1/MDR1 C3435T polymorphism in epilepsy patients receiving carbamazepine. BS Haerian, Z Mohamed, CT Tan, AA Raymond, KS Lim, HJ Tan, EHM Mohamed and VL Raj, Convention of the ASEAN Neurological Association (ASNA) & Neurosciences 2009, 20th Annual Scientific Meeting of the Malaysian Society of Neurosciences 2009, 2009-04-01 to 2009-04-04, (International)
  • Association between the serotonin transporter gene and major depressive disorder in three major ethnic groups in Malaysia. Nor Zainal, Zahurin M, Lian L Hoong, Vijaya L Raj, Elsa M Mohamed, Loke Ai Chin, American Psychiatric Association Annual Meeting, 2009-05-16 to 2009-05-21, (International)
  • SCN1A polymorphism in epilepsy patients receiving carbamazepine. BS Haerian1, EHM Mohamed, KS Lim, HJ Tan, VL Raj, CT Tan, AA Raymond, Z Mohamed, Congress of Neurology & Clinical Electrophysiology of Iran. 19-22 May 2009, 2009-05-19 to 2009-05-22, (International)
  • Association of ABCB1 and NR112 polymorphisms with response to carbamazepine in Malaysian epilepsy patients. BS Haerian, EHM Mohamed, KS Lim, HJ Tan, AA Raymond, CT Tan, CP Wong, SM Zain, SNM Roffeei and Z Mohamed, American Society for Pharmacology and Experimental Therapeutics (ASPET), 2010-04-05 to 2010-04-05, (International)
  • Association of ABCB1 C1236T Polymorphism with Risk of Resistance to Sodium Valproate in Malaysian Epilepsy Patients. Haerian BS, Haslyna O, Mohammad S, Mohamed EHM, Lim KS, Tan HJ, Tan CT, Raymond AA, Wong CP, Wong SW, Mohamed Z, 24th Malaysian Society of Pharmacology & Physiology Scientific Meeting 2010, 2010-06-02 to 2010-06-03, (National)
  • Association of ABCB1 C1236T and C3435T Polymorphisms with the Risk of Resistance to Sodium Valproate in Malaysian Epilepsy Patients. Z Mohamed, Haerian BS, Haslyna O, Mohammad S, Mohamed EHM, Lim KS, Tan HJ, Raymond AA, Wong CP, Wong SW and Tan CT, 24th Malaysian Society of Pharmacology & Physiology Scientific Meeting 2010, 2010-06-02 to 2010-06-03, (National)

EXPERT LINKAGES
(Linkages Description), (Organisation), (Year of Involvement), (Duration), (Level).

  • Conducted a Train the Trainer Course for Prescribing Skills, UiTM, 2018, 1, (National)

EVALUATION ACTIVITIES
(Description), (Evaluation Activity),(Year).

  • Design and Preparation of Polymeric Nanoparticles/Gels for the Transdermal Delivery of Testosterone, Proposal Defence ,  (2018 - 2018)

CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).

  • Interviewer for Tunas Geliga Camp Mock Interview Program, (National), 16/12/2018 until 16/12/2018
  • Volunteer for Teddy Bear Hospital, in conjunction with Malaysian International Children's Festival, (National), 02/12/2018 until 02/12/2018
  • Participated in Research Carnival Run, (University), 17/11/2018 until 17/11/2018
  • Exco member, Islamic Medical Association of Malaysia , (National), 22/10/2018 until 22/10/2020
  • Forum panelist for a forum entitled "Perubatan Moden Tidak Islamik?", (National), 27/09/2018 until 27/12/2018
  • Organised Pharmacology Department Team Building Event, (Department), 16/08/2018 until 16/08/2018
  • Sub-committee member for Annual MSPP Young Teacher''s Award Competition, Faculty of Health Sciences UKM, (National), 27/07/2018 until 27/07/2018
  • Penemuduga untuk Program UMMP Kemasukan 2018/2019, (University), 30/05/2018 until 01/06/2018
  • University of Malaya-University of Edinburgh Research Symposium on Metabolic Syndrome, (International), 04/12/2017 until 06/12/2017
  • Penemuduga bagi Kemasukan ke Program Pengajian Peringkat Ijazah Pertama Fakulti Perubatan Sesi 2018/2018, (University), 23/05/2017 until 25/05/2017
  • Organised Dept of Pharmacology Family Day, (Department), 09/08/2016 until 09/08/2016
  • What you need to know about H1N1 for ABIM Kindergarten Motivation's Day, (District), 16/05/2010 until 16/05/2010
  • Public lecture: \'Personalised Medicine\' at IRIS Malaysia Sdn Bhd, (Community), 13/10/2009 until 13/10/2009
  • Public lecture: What you need to know about stroke at IRIS Malaysia Sdn Bhd, (Community), 16/05/2007 until 16/05/2007

SUPERVISION

FIRST DEGREE/DIPLOMA/PRE-DEGREE
(Course Title), (Academic Session), (No. of Candidates)

Completed
  • Amir Hakim Bin Mohd Yusof Association of uncoupling protein-2 (UCP2) -866 G/A polymorphism with body mass index in multi-ethnic Malaysian population, 2010/2011, 1
  • Noor Hidayah Mohammad Association of fatty acid binding protein-2 (FABP2) A54T Polymorphism with Sodium Valproate Responsiveness in Malaysian Epilepsy Patients, 2009/2010, 1
  • Mohd Izwan Zainol Polymorphism of serotonin 5-HT2C receptor in multi ethnic patients with major depressive disorder, 2008/2009, 1
  • Siti Zaleha Binti Suki. The polymorphism of dopamine D3 receptor in multi-ethnic patients with schizophrenia, 2007/2008, 1
  • Noor Fadzlin Binti Mahali Polymorphism of serotonin 5-HT2C receptor in multi-ethnic patients with schizophrenia, 2007/2008, 1

Ongoing
  • Fatin Nursyamimi Binti Abd Razak . Pomegranate juice extract induces apoptosis, cell cycle arrest and morphological changes in human colon cancer cell, 2018/2019, 1
POST GRADUATE STUDENT
(Name of Degree), (Name of Candidates), (Title of Thesis), (Academic Session)

Ongoing
  • Master Degree, Noor Atiqah Binti Fakharuzi, Detection of somatic aberration in acute myeloid leukemia with normal cytogenetic (CN-AML) in the Malaysian population, 2017/2018

Completed
  • Master Degree, Md. Mirazul Islam, Cytokines and Chemokines Profiling of Adult Malaysian Acute Myeloid Leukemia (AML) Patients and Analysis of Molecular Abnormalities, 2014/2015

TEACHING
(Course Title), (Academic Session), (No of Student), (No of Contact Hours).

FIRST DEGREE
  • PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2018/2019(1), 42, 9
  • PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2017/2018(1), 40, 6
  • UMMP Stage 2, 2017/2018(1), 150, 1.5
  • PHARMACOLOGY, 2017/2018(2), 50, 7
  • UMMP STAGE 1, 2017/2018(2), 150, 6
  • Advances in Medical Pharmacology, 2017/2018(2), 40, 7
  • PHARMACOLOGY, 2017/2018(1), 54, 4
  • UMMP STAGE 1, 2017/2018(1), 150, 2
  • UMMP Stage 2, 2017/2018(2), 150, 10
  • UMMP STAGE 1, 2016/2017(2), 150, 13
  • UMMP Stage 2, 2016/2017(2), 150, 11.5
  • PHARMACOLOGY IN NURSING, 2016/2017(2), 25, 2
  • PHARMACOLOGY, 2016/2017(2), 54, 6